Bowel Preparations for Colonoscopy: A Regulatory Perspective.

Area of Science:

• Gastroenterology
• Clinical Pharmacology

Background:

• Bowel preparation agents are frequently prescribed for colonoscopy.
• Effective bowel preparation is linked to increased adenoma detection rates.
• High safety and efficacy standards are crucial for these agents.

Purpose of the Study:

• To review the standards for clinical trials of bowel preparation agents.
• To identify areas for future research in bowel preparation efficacy and safety.

Main Methods:

• Review of clinical trial designs for bowel preparation agents.
• Discussion of current endpoint assessment instruments.
• Identification of patient populations and adverse events for further study.

Main Results:

• Clinical trials can be designed for superiority or non-inferiority, utilizing various New Drug Applications.
• Current efficacy assessments rely on clinician reporting, potentially needing multiple instruments.
• Orthostatic hemodynamic changes are a recognized, yet understudied, adverse event of bowel preps.

Conclusions:

• Rigorous safety and efficacy evaluation is essential for bowel preparation agents.
• Further investigation into hard-to-prepare patients and those with renal dysfunction is warranted.
• Additional research on the class-wide adverse event of orthostatic hemodynamic changes is needed.